Trial Profile
A Phase 1, Multicenter, Open-label, Single-dose Study to Assess the Pharmacokinetics of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Apr 2017
Price :
$35
*
At a glance
- Drugs Avibactam/ceftaroline fosamil (Primary)
- Indications Bacterial infections; Systemic inflammatory response syndrome
- Focus Pharmacokinetics
- Sponsors Forest Laboratories
- 13 Nov 2012 Planned End Date changed from 1 Jul 2013 to 1 Jan 2014 as reported by ClinicalTrials.gov.
- 26 Jun 2012 New trial record